Why macadamia nuts stand apart from other nuts
Most tree nuts owe their health benefits to a mix of monounsaturated and polyunsaturated fats. Macadamias are distinctive: roughly 65% of their fat is oleic acid and 18–21% is palmitoleic acid — leaving very little room for omega-6 linoleic acid, which makes up 30–60% of the fat in almonds, cashews, and most other nuts [6].
The omega-7 advantage
Palmitoleic acid (C16:1 n-7, or omega-7) has attracted growing interest as a lipokine — a fat-derived signaling molecule that appears to improve insulin sensitivity, reduce atherogenic lipid production in the liver, and modulate inflammation. Macadamia nuts are the richest whole-food plant source of palmitoleic acid. While isolated omega-7 supplements have shown mixed results in clinical trials, consuming palmitoleic acid in the context of a whole food — with fiber, polyphenols, and a favorable overall fatty acid matrix — may behave differently.
Why the low omega-6 content matters
The ratio of omega-6 to omega-3 fatty acids in the diet influences the production of prostaglandins and leukotrienes, signaling molecules that regulate inflammation. Modern Western diets are heavily skewed toward omega-6 (from seed oils, conventional meats, and processed foods), which promotes a more pro-inflammatory state. Macadamias, with essentially no linoleic acid, allow you to add calorie-dense fat to your diet without worsening the omega-6 burden — an unusual property for a plant food.
Cholesterol and cardiovascular health
Multiple controlled trials and a large meta-analysis confirm that macadamia nuts lower LDL and total cholesterol when they replace refined carbohydrates or saturated fat in the diet [1][2][4][5]. Unlike some dietary interventions that lower LDL while also lowering HDL (the "good" cholesterol), macadamia nuts appear to raise HDL while lowering LDL [2] — a more favorable lipid shift for cardiovascular risk. One trial also found a reduction in small, dense LDL particles — the most atherogenic LDL subtype, which penetrates arterial walls most readily [4].
Micronutrient highlights
Manganese — Macadamia nuts are exceptionally high in manganese, a trace mineral required for bone formation, wound healing, and the activity of superoxide dismutase (the body's primary antioxidant enzyme inside cells). One ounce provides around 50–60% of the daily value.
Thiamine (vitamin B1) — Among tree nuts, macadamias have the highest thiamine content — essential for converting carbohydrates to energy and supporting nerve function [7]. Roasting at moderate temperatures reduces thiamine by about 16–18% but leaves the lipid profile largely intact.
Phytosterols and tocopherols — Macadamias contain plant sterols, which compete with dietary cholesterol for absorption in the gut, and tocopherols (vitamin E antioxidants), though in lower amounts than walnuts or almonds [6].
Practical notes
Portion: One ounce (28 g, about 10–12 whole nuts) provides roughly 200 calories, 21 g fat, 2 g fiber, 1.2 mg manganese, and 0.3 mg thiamine. Most clinical trials used 40–90 g per day; 28–56 g daily is a sensible practical target.
Raw vs. roasted: Light dry-roasting at ~150°C preserves the lipid profile well. Heavy oil-roasting, added coatings, or high heat (above 180°C) can degrade heat-sensitive fatty acids and significantly reduce thiamine [7]. Buy raw or lightly roasted without added oils or salt when possible.
For low-carbohydrate diets: At less than 4 g net carbs per ounce, macadamias are the most carbohydrate-compatible tree nut, making them a popular choice in ketogenic and low-glycemic eating patterns.
Storage: The high monounsaturated fat content makes macadamias more shelf-stable than walnuts or flaxseed, but they will still go rancid in heat and light. Store in a sealed container, away from light; refrigeration extends freshness further.
See our Nuts & Seeds overview and Walnuts page for broader context on tree nut health benefits.
Evidence Review
Griel et al. (2008) — PMID 18356332
This randomized crossover trial at Penn State University enrolled 25 mildly hypercholesterolemic adults (baseline LDL ~130 mg/dL). Participants consumed either a macadamia nut-rich diet (providing ~15% of total daily energy from macadamia nuts — approximately 42–90 g/day depending on caloric needs) or a control average-American diet for five weeks each, separated by a two-week washout. The macadamia nut diet was designed to be isocaloric by reducing dietary carbohydrate.
Key findings: Compared to the average American diet, the macadamia nut diet produced statistically significant reductions in:
- Total cholesterol: −9.4%
- LDL cholesterol: −8.9%
- Non-HDL cholesterol: −8.1%
- TC:HDL ratio: −8.3%
- LDL:HDL ratio: −7.6%
HDL cholesterol and triglycerides were unchanged.
Significance: An ~9% reduction in LDL from a single dietary change — replacing carbohydrate with macadamia nuts — is clinically meaningful. The absence of triglyceride elevation distinguishes this from high-carbohydrate dietary patterns, which typically raise triglycerides while lowering LDL. Limitations include the small sample (25 participants) and the controlled feeding design, which may not reflect free-living dietary behavior.
Garg, Blake & Wills (2003) — PMID 12672919
This three-arm crossover trial in Australia enrolled 17 hypercholesterolemic men, cycling them through a high-macadamia nut diet (~40–90 g/day), a high-fat reference diet, and a low-fat reference diet — four weeks per phase. The macadamia nut diet derived ~33% of calories from fat, predominantly MUFAs.
Key findings compared to the high-fat reference diet:
- Total cholesterol: −3.0%
- LDL cholesterol: −5.3%
- HDL cholesterol: +7.9%
- Triglycerides: −9.0%
All four changes moved simultaneously in a favorable direction.
Significance: Dietary interventions rarely improve all four major lipid markers at once. The concurrent rise in HDL alongside LDL reduction is particularly notable, because HDL is inversely associated with cardiovascular event risk. A 5% LDL reduction combined with a nearly 8% HDL increase represents a meaningfully improved TC:HDL ratio. The sample of 17 men limits generalizability, particularly to women and non-hypercholesterolemic populations.
Garg, Blake, Wills & Clayton (2007) — PMID 17437143
A follow-up crossover study in 17 hypercholesterolemic subjects (men and women combined) using a 4-week macadamia nut dietary phase. This trial added measurements of lipoprotein particle subfractions and oxidative stress markers beyond standard lipid panels.
Key findings:
- Total cholesterol: −5.0% (significant)
- LDL cholesterol: −5.3% (significant)
- Triglycerides: −8.3% (significant)
- Significant reduction in small, dense LDL particle concentration
- Favorable non-significant trends in oxidative stress and inflammation markers
Significance: The reduction in small, dense LDL particles is the most important secondary finding. Small, dense LDL (pattern B) is more atherogenic than large, buoyant LDL: it has a longer plasma half-life, penetrates arterial intima more readily, and is more susceptible to oxidative modification. Improving LDL particle quality — not just quantity — provides additional cardiovascular protection beyond what total LDL measurements capture. This study suggests macadamia nuts may influence the composition of LDL, not only its concentration.
Jones et al. (2023) — PMID 37180485
This eight-week randomized crossover trial enrolled 35 overweight or obese adults (BMI 27–40 kg/m²) and tested macadamia nut supplementation at ~15% of daily energy (~42–84 g/day) against a nut-free control, under free-living conditions (participants self-selected the rest of their diet).
Key findings:
- No significant change in body weight or body composition despite nut supplementation (~400–600 added kcal/day)
- Non-significant reductions in total cholesterol (−3.6%) and LDL-C (−5.5%)
- Participants with lower baseline adiposity showed a larger lipid-lowering response
- Fasting glucose, insulin, and HOMA-IR were unchanged
Significance: The absence of weight gain when adding calorie-dense macadamia nuts to a free-living diet suggests that satiety compensation partially offsets the added calories — a finding consistent with other tree nut supplementation trials. The attenuated (and non-significant) lipid effects compared to controlled-feeding trials reflect the difficulty of detecting modest dietary signals against the noise of free-living dietary variability, and the fact that obese subjects with more metabolic dysregulation show different baseline lipid dynamics. The observation that leaner participants responded more robustly has clinical implications: those with elevated cholesterol but lower body fat may derive more benefit.
Del Gobbo et al. (2015) — PMID 26561616
This systematic review and meta-analysis synthesized 61 controlled intervention trials totaling 2,582 participants across multiple nut types — including macadamias, walnuts, almonds, pistachios, cashews, and others. Dose-response modeling estimated lipid effects at a range of daily nut intakes.
Key findings for tree nuts overall:
- Total cholesterol: −4.7 mg/dL per serving (28 g/day)
- LDL cholesterol: −4.8 mg/dL per serving
- ApoB: −3.7 mg/dL per serving
- Triglycerides: −2.2 mg/dL per serving
- HDL cholesterol: no significant change (neutral)
- Effects were strongest in participants with type 2 diabetes and in those with baseline LDL above 130 mg/dL
- The dose-response relationship was approximately linear up to three servings per day
Significance: This large synthesis confirms that macadamia nuts participate in the general tree nut lipid-lowering effect. The macadamia-specific subset was too small for independent analysis, but the overall dose-response data suggest consuming two ounces rather than one per day produces proportionally greater benefits — and that individuals with elevated baseline LDL are most likely to respond meaningfully. The findings across 61 trials spanning diverse populations provide strong confirmation that nut-induced lipid lowering is a robust, replicable effect rather than an artifact of any single study.